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Regulation of conventional protein kinase C isozymes by
phosphoinositide-dependent kinase 1 (PDK-1)
Erica M. Dutil*, Alex Toker† and Alexandra C. Newton*
Background: Phosphorylation critically regulates the catalytic function of most
members of the protein kinase superfamily. One such member, protein kinase C
(PKC), contains two phosphorylation switches: a site on the activation loop that
is phosphorylated by another kinase, and two autophosphorylation sites in the
carboxyl terminus. For conventional PKC isozymes, the mature enzyme, which is
present in the detergent-soluble fraction of cells, is quantitatively
phosphorylated at the carboxy-terminal sites but only partially phosphorylated
on the activation loop.
Results: This study identifies the recently discovered phosphoinositide-
dependent kinase 1, PDK-1, as a regulator of the activation loop of conventional
PKC isozymes. First, studies in vivo revealed that PDK-1 controls the amount of
mature (carboxy-terminally phosphorylated) conventional PKC. More
specifically, co-expression of the conventional PKC isoform PKC βII with a
catalytically inactive form of PDK-1 in COS-7 cells resulted in both the
accumulation of non-phosphorylated PKC and a corresponding decrease in
PKC activity. Second, studies in vitro using purified proteins established that
PDK-1 specifically phosphorylates the activation loop of PKC α and βII. The
phosphorylation of the mature PKC enzyme did not modulate its basal activity or
its maximal cofactor-dependent activity. Rather, the phosphorylation of non-
phosphorylated enzyme by PDK-1 triggered carboxy-terminal phosphorylation of
PKC, thus providing the first step in the generation of catalytically competent
(mature) enzyme.
Conclusions: We have shown that PDK-1 controls the phosphorylation of
conventional PKC isozymes in vivo. Studies performed in vitro establish that
PDK-1 directly phosphorylates PKC on the activation loop, thereby allowing
carboxy-terminal phosphorylation of PKC. These data suggest that
phosphorylation of the activation loop by PDK-1 provides the first step in the
processing of conventional PKC isozymes by phosphorylation.
Background
The elucidation of the first crystal structure of a kinase,
that of protein kinase A, unveiled a key regulatory switch
in kinase function: phosphorylation of the activation loop
(reviewed in [1]). Ionic interactions between a critically
positioned phosphate group, located on a conserved loop
near the entrance to the active site, and residues within
the active site were shown to correctly align residues for
catalysis. This phosphorylation switch is found throughout
the kinase superfamily, being shared by both tyrosine
kinases and serine/threonine kinases [2]. For some
kinases, such as protein kinase A, phosphorylation of the
activation loop occurs during the maturation of the
enzyme, with activation of the kinase resulting from sub-
sequent interactions with second messengers [3]. For
others, such as the cyclin-dependent kinase Cdk2 and the
mitogen-activated protein (MAP) kinases, phosphoryla-
tion is triggered by specific stimuli and serves as the direct
switch to activate the enzymes [4,5]. One class of kinases
that is regulated by phosphorylation at the activation loop
is the protein kinase C (PKC) family.
PKC isozymes transduce the myriad of signals promoting
phospholipid hydrolysis [6]. This family of enzymes com-
prises three subclasses: conventional (α, βI, βII and γ),
novel (δ, ε, θ and η/L) and atypical (ζ and λ/ι). For con-
ventional and novel isozymes, the generation of diacyl-
glycerol by phospholipase C or D recruits cytosolic PKC to
the membrane. Binding of PKC to the membrane is medi-
ated by two membrane-targeting domains, C1 and C2,
which, upon interaction with their ligands diacylglycerol
and phosphatidylserine, provide the energy to release an
autoinhibitory (pseudosubstrate) domain from the active
site [7]. The regulation of atypical PKC isozymes differs
in that diacylglycerol does not regulate the function of the
enzyme. Rather, mounting evidence has implicated 
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phosphoinositide (PI)3-kinase as providing the stimulus to
activate these PKC isozymes.
Before PKC is competent to respond to second messen-
gers, it must first be phosphorylated at three conserved
positions: the activation loop and two positions at the car-
boxyl terminus of the protein. These positions are
Thr500, Thr641 and Ser660 in PKC βII [8,9]. Hydroxyl-
containing residues are found at corresponding positions
throughout the PKC family, with the exception of the
atypical PKC isozymes, which have a glutamic acid
residue at the position corresponding to Ser660 [9].
Biochemical studies indicate that the phosphorylation of
the activation loop is a transphosphorylation event medi-
ated by another kinase [9,10]. In contrast, the two
carboxy-terminal phosphorylations have been shown to be
autophosphorylation events in vitro [9,11]. The phospho-
rylation of the activation loop appears to occur first,
leading to the hypothesis that transphosphorylation at this
position alters the conformation of the kinase, so as to
allow for the two autophosphorylations at the carboxyl ter-
minus. Once phosphorylated at the two carboxy-terminal
positions, the conventional PKC isozymess no longer
require phosphate at the activation loop to be catalytically
competent: dephosphorylation of mature (that is, carboxy-
terminally phosphorylated) PKC βII at Thr500 does not
affect the maximal activity of the enzyme [12].
The recently discovered PI-dependent protein kinases
(PDKs) are ideal candidates for catalyzing the phosphoryla-
tion of the activation loop of PKC: PDK-1 phosphorylates
the activation loop of protein kinase B (PKB or Akt) on a
sequence that has a high similarity to that found in the acti-
vation loop of PKC [13]. PDK-1 also phosphorylates the
related kinases p70S6 kinase and protein kinase A [3,14,15].
The phosphorylation of PKB is triggered by the generation
of phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3)
through PI3-kinase; this lipid binds to the pleckstrin homol-
ogy (PH) domain of PKB, causing a conformational change
that exposes the phosphorylatable threonine residue on the
activation loop [16,17]. Although PDK-1 itself contains a PH
domain, ligand-binding to this domain does not appear to be
essential for catalysis [16]. Rather, the PH domain of PDK-1
may serve to localize PDK-1 near its membrane-bound sub-
strates [17,18]. The studies with PKB suggest that, at least
for one kinase, phosphorylation at the activation loop by
PDK-1 is regulated by the substrate conformation.
This study explores the phosphorylation of the conven-
tional PKC isozymes by PDK-1. More specifically, we
have shown that PDK-1 regulates the phosphorylation
state of PKC in COS-7 cells and catalyzes the direct phos-
phorylation of the activation loop of PKC in vitro. Thus,
PDK-1 provides the trigger to initiate the processing of
conventional PKC isozymes by phosphorylation.
Results
Regulation of PKC by PDK-1 in vivo
To test whether PDK-1 regulates the function of the
conventional PKC isozymes in vivo, we examined
whether the phosphorylation of PKC βII was different in
COS-7 cells co-expressing either wild-type PDK-1 or the
kinase-inactive PDK-1inact. Cells were transfected with
vector alone, PKC βII, PKC βII and PDK-1, or PKC βII
and inactive PDK-1inact; cell lysates were then subjected
to SDS–PAGE and western blotting and probed either
with an antibody that does not discriminate between
phosphorylation states or with an antibody (P500) that
specifically recognizes the phosphorylated activation
loop [19].
Figure 1a shows that when PKC βII is expressed in COS-7
cells, it migrates as a doublet in SDS–PAGE (lane 2). We
have previously shown that the upper band represents
protein that is quantitatively phosphorylated at the two
carboxy-terminal positions and partially phosphorylated at
the activation loop; this species, referred to as mature
PKC, partitions exclusively in the detergent-soluble cell
fraction [9]. The lower band represents protein that has
not been phosphorylated at either of the carboxy-terminal
sites (an intermediate band, not visible in Figure 1a, con-
tains protein that is phosphorylated at Thr641 but not
Ser660) [9,20]). Co-expression of PDK-1 resulted in a
decrease in the amount of faster-migrating PKC βII
(Figure 1a, lane 3). Conversely, co-expression of
PDK-1inact resulted in a marked increase in the amount of
faster-migrating PKC βII (Figure 1a, lane 4). Quantitative
analysis revealed that the lower band represented 23 ± 3%
of the total PKC in the absence of co-expressed PDK-1,
12.6 ± 0.6 % in the presence of PDK-1, and 38 ± 9% in the
presence of PDK-1inact (Figure 1a, lanes 2,3,4, respec-
tively). Thus, overexpression of PDK-1 resulted in the
generation of a larger fraction of mature PKC, whereas
overexpression of the kinase-inactive PDK-1inact resulted
in the accumulation of non-phosphorylated PKC. In all
cases, the lower band partitioned in the detergent-insolu-
ble cell fraction (data not shown). The expression of the
PDK-1 constructs was confirmed by reprobing blots with
anti-Myc antibodies (data not shown).
Figure 1a also shows the result of probing the blot of
COS-7 cell lysates with the antibody P500. When normal-
ized to the immunoreactivity obtained with the non-dis-
criminatory antibody, no significant differences were
noted between the phosphorylation state of the activation
loop of the various samples. In other words, overexpres-
sion of wild-type PDK-1 or the kinase-inactive PDK-1inact
had no readily detectable effect on the degree of phospho-
rylation of the activation loop of mature PKC (Figure 1a,
slower-migrating band) under the transfection conditions
of these experiments. Thus, PDK-1 affects the fraction of
PKC βII that is processed to the mature form, but does
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not detectably affect the fraction of mature form that is
phosphorylated on the activation loop.
The effect of overexpressing active or inactive PDK-1 on
the PKC activity in COS-7 cells overexpressing PKC βII is
presented in Figure 1b. Co-expression of PDK-1 and
PKC βII resulted in a twofold increase in the total kinase
activity relative to cells transfected with vector alone; this
increase represents that resulting from PKC βII expres-
sion and was not significantly affected by co-expression of
PDK-1 (data not shown). Co-expression of PDK-1inact
resulted in a marked reduction in the total PKC activity.
This reduction probably reflects a decrease in the activity
of both the transfected PKC βII and the endogenous
PKC α. Thus, PDK-1inact serves as a dominant-negative
inhibitor of PKC activity.
We also explored the effect of co-expressing PDK-1 or
PDK-1inact with PKC α. Figure 2 shows that co-expression
of PDK-1inact resulted in an approximately 60% reduction
in the fraction of mature PKC α that was phosphorylated
on the activation loop relative to that present in cells co-
expressing wild-type PDK-1.
We next addressed whether PDK-1 forms a complex with
PKC βII in vivo. 293 cells were co-transfected with vectors
encoding Myc-tagged PDK-1 and PKC βII. The PDK-1
was subsequently immunoprecipitated and the resulting
immunoprecipitates analyzed for the presence of PKC βII.
Figure 3a shows that PKC βII was present in immunopre-
cipitates from both serum-starved (lane 2), or serum-treated
(lane 3) cells. The amount of PKC βII in the immunopre-
cipitates was insensitive to the presence of wortmannin, an
inhibitor of PI3-kinase (lane 4). Note that the PKC βII
migrated as a doublet, probably reflecting the presence of
both the phosphorylated and dephosphorylated species of
the enzyme; both forms were present in western blots of
whole cell lysates (data not shown; the large fraction of
faster-migrating species typically arises as a result of serum-
starvation, which promotes the dephosphorylation of PKC;
A.S. Edwards and A.C.N., unpublished observations). No
PKC βII was detected in cells transfected with PDK-1
alone (Figure 3a, lane 1). Figure 3b shows the presence of
Myc-tagged PDK-1 in whole cell lysates from all transfec-
tions. Western blot analysis of whole cell lysates also
demonstrated that comparable levels of PKC βII were
expressed in all transfections (data not shown). These data
reveal that PDK-1 and PKC βII associate in cells and that
this association is not modulated by serum starvation or
inhibitors of PI3-kinase.
Figure 1
Co-expression of PDK-1 or PDK-1inact with
PKC βII in COS-7 cells affects the fraction of
mature PKC and the specific activity of PKC.
(a) Western blots of lysates of COS-7 cells
transfected with the pcDNA3 vector DNA
alone (lanes 1,5), or with vectors carrying PKC
βII (lanes 2,6), PKC βII and PDK-1 (lanes 3,7),
or PKC βII and PDK-1inact (lanes 4,8). The
blots were probed with a non-discriminatory
antibody against PKC βII (PKCβII,
Calbiochem; lanes 1–4) or with an antibody
that specifically labels the phosphorylated
activation loop (P500; lanes 5–8). A double
asterisk indicates the position at which mature
PKC migrates; a single asterisk denotes the
position at which non-phosphorylated PKC
migrates. The results are representative of five
independent transfections. (b) PKC activity
was measured in the presence or absence of
phosphatidylserine, diacylglycerol and Ca2+, in
lysates of COS-7 cells transfected with vector
alone (pcDNA3), PKC βII and PDK-1, or
PKC βII and PDK-1inact. The data are
presented as the mean ± SEM of sextuplicate
assays from the transfections in (a).
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Figure 2
Co-expression of PDK-1 or PDK-1inact with PKC α affects the fraction of
mature PKC that is phosphorylated on the activation loop. Western blots
of lysates of COS-7 cells transfected with pcDNA3 alone (lanes 1,4), or
with vectors carrying PKC α and PDK-1 (lanes 2,5), or PKC α and PDK-
1inact (lanes 3,6). The blots were probed using two antibodies: a non-
discriminatory antibody against PKC α (PKCα; Transduction
Laboratories) and the P500 antibody. The ratio of P500
immunoreactivity to PKC α immunoreactivity, which was obtained by
densitometric analysis of the data, is shown in arbitrary units under lanes
4–6. The data are representative of three independent transfections.
P500: PKCα
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Phosphorylation of conventional PKC isozymes by PDK-1
in vitro
The above experiments reveal that PDK-1 alters the frac-
tion of mature PKC βII and forms a complex with this
isozyme in vivo. This led us to ask whether PDK-1
directly phosphorylates the activation loop of conven-
tional PKC isozymes. To this end, we incubated baculovi-
rally expressed PKC α or βII with either pure wild-type
PDK-1 or PDK-1inact, in the presence of Mg2+–ATP. We
used two forms of PKC: protein that was quantitatively
phosphorylated at the two carboxy-terminal positions and
partially dephosphorylated on the activation loop (mature
PKC), or dephosphorylated protein. The former repre-
sents native PKC isolated from the detergent-soluble frac-
tion of insect cells — mass spectrometric analysis
previously established that approximately 60% of this
PKC is phosphorylated on the activation loop and quanti-
tatively phosphorylated on the two carboxy-terminal posi-
tions [9]. The latter form of PKC was generated by
treating native PKC with the catalytic subunit of protein
phosphatase 1 [12]. Phosphorylation on the activation
loop was detected using the P500 antibody.
Figure 4a shows that incubation with wild-type PDK-1
resulted in a significant increase in the phosphorylation of
the activation loop of both mature PKC α (lane 2) and
PKC βII (lane 6) relative to the basal phosphorylation
state observed upon incubation with no kinase (data not
shown) or with PDK-1inact (lanes 1,5). Immunoreactivity
increased by approximately 40% upon incubation with
wild-type PDK-1, which is consistent with almost com-
plete phosphorylation of the activation loop. This
increased immunoreactivity did not result from changes in
the amount of PKC, as assessed by probing blots with
antibodies to each isozyme that do not discriminate
between the different phosphorylation states of PKC
(Figure 4a, lanes 3,4,7,8).
Figure 4b shows that the phosphorylation of mature
PKC βII by PDK-1 did not depend on the PKC activators
phosphatidylserine and Ca2+, or on the presence of
PI(3,4,5)P3. The initial rate of phosphorylation was the
same (approximately 0.01 pmol phosphate incorporated per
minute) in the absence of vesicles (open circles), or in the
presence of phosphatidylcholine vesicles containing phos-
phatidylserine and diacylglycerol (filled circles), PI(3,4,5)P3
(open squares), or phosphatidylserine, diacylglycerol and
Figure 3
PKC βII associates with PDK-1 in vivo. 293 cells were transfected
with the cDNA for Myc-tagged PDK-1 (lanes 1–4) and PKC βII
(lanes 2–4). The transfected cells were serum-starved for 24 h, and
then treated with 10% foetal bovine serum (FBS) for 20 min (lane 3),
or with 10% FBS and 100 nM wortmannin for 10 min (lane 4).
(a) PDK-1 was immunoprecipitated from lysates using an anti-Myc
monoclonal antibody, and western blots of precipitated protein were
probed for PKC βII (Santa Cruz antibody). (b) Blot of whole cell
lysate from the transfected cells probed with an anti-Myc antibody to
detect PDK-1 expression.
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Figure 4
PDK-1 phosphorylates the activation loop of conventional PKC
isozymes in vitro. (a) Western blots of mature PKC α (lanes 1–4) and
PKC βII (lanes 5–8) after incubation with Mg2+–ATP and either wild-
type PDK-1 (lanes 2,4,6,8) or PDK-1inact (lanes 1,3,5,7); PKC and
PDK-1 concentrations were 3 nM and 40 nM, respectively. The blot
was probed with P500 antibody (lanes 1,2,5,6), or with non-
discriminatory antibodies against PKC α (Transduction Laboratories;
lanes 3,4) or PKC βII (Santa Cruz; lanes 7,8). (b) PKC (3 nM) was
incubated with PDK-1 (40 nM) and Mg2+–ATP for the indicated times
in the absence (open circles) or presence of sonicated
phosphatidylcholine vesicles containing 40 mol% phosphatidylserine
and 5 mol% diacylglycerol (filled circles), 10 mol% PI(3,4,5)P3 (open
squares), or 40% phosphatidylserine, 5 mol% diacylglycerol and
10 mol% PI(3,4,5)P3 (filled squares); where mol% refers to the
percentage of each lipid species in the vesicle membrane on a molar
basis. The reaction mixture contained 200 µM CaCl2.
(b)
PKCα
PKCαP500
97
66
1 2 3 4
(a)
P500 PKCβII
PKCβII
5 6 7 8
97
kDa kDa
66
Time (min)
P
50
0 
re
ac
tiv
ity
 (f
ol
d 
in
cr
ea
se
)
806040200
1
2
3
Current Biology   
PI(3,4,5)P3 (filled squares). Thus, the rate of phosphoryla-
tion of PKC was not sensitive to whether it was membrane
associated, nor did it require the active conformation of
the enzyme.
To explore whether the phosphorylation by PDK-1 was
limited to the activation loop, we examined the phosphory-
lation of a bacterially expressed kinase domain (this con-
struct is inactive and therefore does not autophosphorylate).
The western blot in Figure 5a shows that a construct com-
prising residues 286–673 of PKC βII was phosphorylated on
the activation loop by PDK-1 (lane 3; P500), but was not
phosphorylated on the carboxy-terminal phosphorylation
sites Thr634 or Thr641 (lane 3; P634) or Ser660 (lane 3;
P660). Antibodies that selectively recognize phosphate on
these latter positions recognized similar amounts of
mature PKC βII (Figure 5a, lane 1) but did not recognize
the kinase domain constructs (Figure 5a, lane 2). Consis-
tent with the specific phosphorylation of the activation
loop, a construct in which the activation loop threonine
(Thr500) and two adjacent threonine residues (Thr497
and Thr498) were replaced with alanine residues was not
radiolabeled following incubation with PDK-1 and
[32P]ATP (data not shown), whereas the wild-type kinase
construct was effectively labelled with 32P (Figure 5b).
These data indicate that Thr500 is the sole substrate in
the kinase domain for PDK-1. 
Figure 5b presents a time course for the phosphorylation
of the catalytic domain of PKC following incubation with
PDK-1. After 60 minutes, 0.2 mol phosphate were incor-
porated per mol PKC. This stoichiometry increased to 0.4
upon the renewed addition of PDK-1, indicating that the
substoichiometric phosphorylation was due to PDK-1
losing activity rather than to saturation of substrate sites.
The effect of phosphorylation by PDK-1 on PKC activity
We next addressed whether the phosphorylation by PDK-1
affected either the basal or the cofactor-dependent activity
of mature PKC. As described for the experiments in
Figure 4, PKC was stoichiometrically phosphorylated by
PDK-1. Figure 6 shows that the basal (cofactor-indepen-
dent) activity of PKC α, βII or a mixture of rat brain
isozymes was similar following phosphorylation by PDK-1
(columns 2, 6 and 10, respectively) or following incubation
with PDK-1inact (columns 4, 8 and 12, respectively). Thus,
phosphorylation of the activation loop of mature enzyme
does not activate the conventional PKC isozymes. Nor did
phosphorylation by PDK-1 increase the maximal rate of
catalysis observed in the presence of saturating levels of the
cofactors Ca2+, phosphatidylserine and diacylglycerol
(compare columns 1 and 3, 5 and 7, and 9 and 11). Curiously,
we noted that the activity of PKC following incubation with
PDK-1inact was typically slightly elevated relative to that fol-
lowing incubation with wild-type PDK-1 or with no PDK-1
(data not shown). The finding that phosphorylation by
PDK-1 does not significantly affect the maximal catalytic
rate of mature PKC is consistent with previous findings
showing that dephosphorylation of Thr500 and Ser660 of
mature PKC βII does not affect the enzyme’s Vmax [9,12].
The above data revealed that PDK-1 does not regulate the
activity of mature PKC. This led us to ask the question:
does PDK-1 regulate the activity of non-phosphorylated
enzyme? Pure PKC βII was treated with protein phos-
phatase 1 under conditions that resulted in the quantita-
tive dephosphorylation of the enzyme and a complete loss
of enzymatic activity [9,12]. The dephosphorylated
protein was then incubated with PDK-1 and Mg2+–ATP in
the presence of PKC activators, and the phosphorylation
1370 Current Biology, Vol 8 No 25
Figure 5
PDK-1 specifically phosphorylates the activation loop of the bacterially
expressed kinase domain of PKC βII. (a) Western blots of lysates from
cells transfected with a construct carrying the kinase domain of
PKC βII (50 nM) following incubation with either PDK-1 (30 nM;
lane 3) or PDK-1inact (lane 2) in the presence of Mg2+–ATP. The blots
were probed with P500 antibody, or with an antibody that recognizes
phosphorylated Thr643 and, to a much lower extent, phosphorylated
Thr641 (P634), or with an antibody that recognizes phosphorylated
Ser660 (P660). Lane 1 contains mature, full-length PKC from the
same blots. (b) The time course of phosphorylation by PDK-1 of the
bacterially expressed kinase domain of PKC βII. The purified catalytic
domain (15 nM) was incubated with PDK-1 (80 nM) in the presence of
Mg2+–ATP for the indicated times. The arrow denotes when an
additional aliquot of PDK-1 was added to the reaction mixture.
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state of the protein was subsequently examined using
antibodies that specifically recognize the activation loop,
the in vitro autophosphorylation site Thr634 [21], or the in
vivo autophosphorylation site Ser660. 
Figure 7 shows that the treatment of mature PKC with
protein phosphatase 1 resulted in the loss of immunoreac-
tivity to the P500 and P660 antibodies and an increase in
electrophoretic mobility (lane 3) relative to the untreated
enzyme (lane 1). The untreated enzyme was not signifi-
cantly labeled by the P634 antibody (this antibody weakly
recognizes P641 [21]). The autophosphorylation of PKC in
vitro (Figure 7, lane 2), however, resulted in a dramatic
increase in reactivity to the P634 antibody, due to intramol-
ecular autophosphorylation on Thr634 [11]. The incubation
of quantitatively dephosphorylated PKC βII with active
PDK-1 (Figure 7, lane 5), but not with PDK-1inact (Figure 7,
lane 4), resulted in phosphorylation of the activation loop.
Thus, PDK-1 phosphorylates the activation loop of PKC
βII independently of whether or not the carboxyl terminus
is phosphorylated. Importantly, phosphorylation of the acti-
vation loop was accompanied by phosphate incorporation
into Ser660 (Figure 7, lane 5, P660 panel). In addition, 
the PDK-1-treated enzyme was heavily phosphorylated 
on the in vitro autophosphorylation site, Thr634: the 
degree of phosphorylation of the phosphatase-treated, 
re-phosphorylated sample (Figure 7, lane 5) was similar to
that of native enzyme allowed to autophosphorylate in vitro
(Figure 7, lane 2). Note that approximately half of the PKC
in the PDK-1-treated sample had a decreased elec-
trophoretic mobility, indicating that half of the protein had
been phosphorylated at the carboxyl terminus. These data
suggest that PDK-1 phosphorylation at the activation loop
triggers the autophosphorylation activity of PKC.
Discussion
Data from studies in vivo and in vitro suggest that PDK-1
controls the activation-loop phosphorylation switch of the
conventional PKC isozymes. More specifically, the data
presented here establish that PDK-1 phosphorylates the
activation loop of conventional PKC isozymes, and that
this phosphorylation controls the maturation of PKC but
does not actually modulate the activity of mature
(carboxy-terminally phosphorylated) enzyme.
PDK-1 phosphorylates the activation loop of conventional
PKC isozymes
Experiments performed in vitro reveal that PDK-1 directly
and specifically phosphorylates the activation loop of the
Figure 6
Phosphorylation by PDK-1 does not affect the activity of conventional
PKC isozymes. PKC α, βII and a mixture of isozymes (PKC mix) were
incubated with purified PDK-1 or PDK-1inact in the presence of
Mg2+–ATP. Following this incubation, PKC activity was measured in
the presence or absence of PKC activators (phosphatidylserine,
diacylglycerol and Ca2+), as described in Materials and methods. The
data represent the mean ± SEM of triplicate assays.
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Figure 7
The phosphorylation of dephosphorylated PKC on its activation loop
triggers carboxy-terminal phosphorylation. PKC βII (3 nM) was treated
with the catalytic subunit of protein phosphatase 1 to effect quantitative
dephosphorylation. The dephosphorylated enzyme was then incubated
with PDK-1inact or PDK-1 (30 nM) and Mg2+–ATP. Western blots show
wild-type PKC (lane 1), wild-type enzyme that was autophosphorylated
in vitro (lane 2), wild-type enzyme treated with protein phosphatase 1
(lane 3) and then incubated with PDK-1inact (lane 4) or wild-type PDK-1
(lane 5). The blots were probed with a non-discriminatory antibody
against PKC βII (PKCβII; Santa Cruz), P500 antibody, and antibodies
that recognize phospho-Thr634 (P634) or phospho-Ser660 (P660).
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conventional PKC isozymes. This phosphorylation is inde-
pendent of the phosphorylation state of the carboxyl ter-
minus: mature PKC that is quantitatively phosphorylated
at the carboxy-terminal sites, the bacterially expressed
kinase domain that has never been phosphorylated, or
mature PKC that has been dephosphorylated in vitro all
serve as effective substrates for PDK-1. Neither does this
phosphorylation appear to require the binding of cofactor
to either kinase: PDK-1 phosphorylated mature PKC at
the same rate in the absence or presence of PKC’s cofac-
tors or PI(3,4,5)P3. Curiously, molecular modeling suggests
that occupation of the active site by the pseudosubstrate
effectively masks Thr500 [22]. Consistent with this pro-
posal, the activation-loop phosphate group is relatively
resistant to phosphatases when the pseudosubstrate occu-
pies the active site; efficient dephosphorylation requires
the active conformation of PKC [12]. It is thus surprising
that for the reverse reaction, access of PDK-1 to Thr500 is
not dependent upon pseudosubstrate removal. The eluci-
dation of the crystal structures of a number of kinases with
or without activation loop phosphates reveals dramatic
changes in the conformation of this loop, however [1,2,4].
Thus, one possibility is that the non-phosphorylated acti-
vation loop of PKC is unstructured and much more acces-
sible than the phosphorylated activation loop. If this is the
case, phosphorylation would not require pseudosubstrate
exposure, whereas dephosphorylation would require the
active conformation of the enzyme.
Activation-loop phosphorylation does not regulate the
maximal activity of mature PKC
In vitro kinase assays revealed that phosphorylation of the
activation loop of mature conventional PKC isozymes has
no detectable effect on their maximal catalytic activity.
Phosphorylation by PDK-1 had no significant effect on
either the basal activity or lipid–Ca2+-stimulated activity
of PKC α, βII or a mixture of rat brain PKC isozymes.
Analysis of phosphorylation-site mutants previously led to
the suggestion that negative charge on the activation loop
is an essential prerequisite to forming catalytically compe-
tent PKC but that, once the mature enzyme is formed, the
phosphate group on the activation loop is not necessary for
catalysis. First, mutation of Thr500 to valine in PKC βII,
or of the corresponding Thr497 to alanine in PKC α,
results in a form of kinase that cannot achieve catalytic
competence: it cannot be activated by cofactors [23,24]
and it is not phosphorylated at the carboxyl terminus (A.S.
Edwards and A.C.N., unpublished observations). Second,
dephosphorylation studies have revealed that once PKC
has been processed by the two carboxy-terminal phospho-
rylations, negative charge at the activation loop is no
longer required for catalysis: treatment of mature PKC
with protein phosphatase 2A dephosphorylates the activa-
tion loop and Ser660, producing a kinase that has the same
Vmax as the mature PKC [9,12]. The lack of effect of acti-
vation-loop phosphorylation on the maximal catalytic
activity of conventional PKC isozymes noted in this study
confirms that phosphate on the activation loop does not
affect the catalytic rate of mature (carboxy-terminally
phosphorylated) PKC. Thus, phosphorylation of the acti-
vation loop is required to prime the conventional PKC
isozymes to permit the two rapid (auto)phosphorylations
at the carboxyl terminus. The phosphorylation of sub-
strate by PKC is dependent on cofactor binding, however.
Phosphorylation of the activation loop triggers carboxy-
terminal phosphorylation of unphosphorylated enzyme 
When mature PKC is quantitatively dephosphorylated by
treatment with protein phosphatase 1, the enzyme is inac-
tivated and incapable of re-autophosphorylation [12]. Here,
we show that phosphorylation of the activation loop by
PDK-1 results in the re-activation of PKC, as assessed by
the re-incorporation of phosphate on the in vivo autophos-
phorylation site Ser660 and the in vitro autophosphoryla-
tion site, Thr634. The bacterially expressed kinase domain
of PKC is phosphorylated by PDK-1 only on Thr500 and
not on the carboxy-terminal sites, suggesting that the
carboxy-terminal sites are not substrates for PDK-1 (the
bacterially expressed PKC is catalytically inactive, even
when a mutant form of PKC containing a glutamic acid
residue instead of threonine at position 500 is expressed,
suggesting that inactivity results from misfolding). 
PDK-1 regulates the fraction of mature PKC bII in vivo 
Co-expression studies revealed that PDK-1 regulates the
fraction of mature PKC βII in COS-7 cells. Under our cell
culture conditions, typically about 20% of the total
expressed PKC βII is not phosphorylated, as assessed by
its increased mobility on SDS–PAGE ([9] and Figure 4).
This pool of PKC partitions with the detergent-insoluble
fraction; phosphorylation at the two carboxy-terminal sites
coincides with the release of the enzyme into the deter-
gent-soluble fraction [9,20]. In this study, we show that
co-expression with PDK-1 resulted in a twofold reduction
in the amount of faster-migrating, non-phosphorylated
PKC. In contrast, co-expression with PDK-1inact resulted
in an almost twofold increase in the amount of faster-
migrating, non-phosphorylated PKC βII. These results
suggest that phosphorylation by PDK-1 provides the first,
and possibly rate-limiting, step in the processing of PKC
by phosphorylation: this processing is accelerated when
PDK-1 is overexpressed, and is inhibited in the presence
of the dominant–negative PDK-1inact. 
Results from this study also showed that the fraction of
mature PKC βII that is phosphorylated on the activation
loop was not detectably affected by overexpression of the
kinase-active or kinase-inactive PDK-1 constructs. In con-
trast, co-expression of PDK-1inact caused an approximately
twofold reduction in the fraction of mature PKC α overex-
pressed in COS-7 cells relative to co-expression of the wild-
type PDK-1. Mass-spectrometric analysis has previously
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established that approximately 60% of the PKC present in
the detergent-soluble fraction of mammalian tissue (bovine
retinas) or insect cells is phosphorylated on the activation
loop [9]. If phosphorylation of the activation loop is
required to process mature PKC, as mutagenesis data
suggest, then phosphatases must regulate the phosphoryla-
tion state of the activation loop of mature PKC. The
current data would thus indicate that overexpression of
PDK-1 can alter the equilibrium between the dephospho-
rylated and phosphorylated mature PKC; this effect was
more evident for PKC α than for PKC βII.
PDK-1 associates with PKC bII in vivo
Co-immunoprecipitation experiments revealed that
PKC βII associates with PDK-1 in vivo. This association
was independent of modulation by PI3-kinase: similar
amounts of PKC βII associated with PDK-1 in serum-
starved, serum-treated or wortmannin-treated 293 cells.
These data suggest that PDK-1 associates constitutively
with conventional PKC isozymes. 
Contrasting roles of activation-loop phosphorylation in
conventional and atypical PKC isozymes 
For conventional PKC isozymes, phosphorylation of the
activation loop is required to process mature PKC
[10,23,24]. This phosphorylation does not, however, regu-
late the maximal catalytic activity of the mature enzyme.
Activation results from the specific interaction of its regu-
latory domains with the second messenger diacylglycerol
and with phosphatidylserine; these interactions provide
the energy to release the autoinhibitory pseudosubstrate
domain from the active site. A similar role for the phospho-
rylation of the activation loop has been ascribed to protein
kinase A, in which phosphorylation of the activation loop is
required for the maturation of this kinase. As with PKC,
this phosphorylation event does not activate protein kinase
A, but rather, cAMP binding to the regulatory subunit is
required to release an autoinhibitory domain from the
active site [25]. Thus, the conventional PKC isozymes and
protein kinase A have two regulatory switches: phosphory-
lation of the activation loop, which renders the enzyme
catalytically competent (that is, capable of becoming acti-
vated), and cofactor binding, which removes the autoin-
hibitory domain from the active site. 
The regulation of conventional PKC isozymes by PDK con-
trasts strikingly with its regulation of the atypical PKC
isozymes. Recently, PKC ζ has been shown to be phospho-
rylated by PDK-1 on its activation loop, an event which
serves as a molecular switch to turn on the catalytic activity
of the kinase [19,26]. This phosphorylation-dependent acti-
vation occurs in the absence of cofactors, although it is stim-
ulated by the presence of phospholipid mixtures containing
PI(3,4,5)P3. Thus, this phosphorylation event is similar to
that of PKB, which is stimulated by PI(3,4,5)P3, and con-
trasts with that of the conventional PKC isozymes, which is
independent of PI(3,4,5)P3 and thus more similar to that of
p70S6 kinase. The direct activation of PKC ζ resulting from
phosphorylation of the activation loop suggests that the
atypical PKC isozymes are regulated by a mechanism that is
similar to that of Cdk2: phosphorylation of the activation
loop serves as a direct ‘on–off’ switch for catalysis [4].
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Figure 8
Model showing the proposed role of PDK-1 in
the processing of conventional PKC
isozymes. Newly synthesized PKC is shown
on the far left in a conformation in which the
activation loop is disordered. The loop lies to
the left of the kinase domain (blue circle with
a cleft representing active site); the carboxyl
terminus is shown as occupying the active
site (based on finding that
autophosphorylation here proceeds by an
intramolecular reaction [11,30]) and the
pseudosubstrate (green rectangle) is shown
displaced from the active site (based on
finding that the pseudosubstrate in precursor
PKC is proteolytically labile; E.M.D. and
A.C.N., unpublished observations).
Phosphorylation by PDK-1 on the activation
loop (Thr500 in PKC βII) is the first event in
the processing of PKC; this phosphorylation
does not appear to be regulated by cofactors
for either kinase. It appears to be the first step
in the maturation of PKC, as overexpression
of a kinase-inactive PDK-1 results in
accumulation of unphosphorylated, precursor
PKC. The transphosphorylation is followed by
two rapid autophosphorylations at the
carboxyl terminus (Thr641 and Ser660 in
PKC βII) that lock PKC in a catalytically
competent conformation [19,31]).
Phosphates are shown in pink. The mature
enzyme phosphorylated at three positions
localizes to the cytosol where it is competent
to respond to second messengers. This
species of PKC is subject to a specific
dephosphorylation at the activation loop
(lower right), an event that does not affect the
enzyme’s cofactor-dependent activation. The
generation of diacylglycerol (DG) causes
mature PKC to translocate to the membrane
(upper right), where the interaction of its two
membrane-targeting domains, C1 (orange
oval) and C2 (yellow oval), with diacylglycerol
and phosphatidylserine provides the energy
to release the pseudosubstrate from the
active site. 
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Conclusions
The above data reveal that PDK-1 phosphorylates the
activation loop of conventional PKC isozymes, and that
this phosphorylation is a step required for the maturation
of conventional PKC isozymes. This phosphorylation does
not activate PKC, but rather, it serves to trigger the two
carboxy-terminal (auto)phosphorylations that are required
to lock PKC in a catalytically competent conformation.
Once this mature conformation is achieved, the phosphate
group on the activation loop does not regulate the activity
of the enzyme. The mature enzyme is activated by cofac-
tor binding, which releases the pseudosubstrate from the
active site (Figure 8). Dual regulation by phosphorylation
and cofactors affords exquisite sensitivity in the molecular
mechanisms regulating kinase function.
Materials and methods
Antibodies and constructs
Bovine brain L-α-phosphatidylserine and sn-1,2-dioleoylglycerol were
obtained from Avanti Polar Lipids. PI(3,4,5)P3 was obtained from
Matreya. Polyvinylidene difluoride (PVDF) membranes were purchased
from Millipore. Triton X-100, microcystin, and peroxidase-conjugated
goat anti-rabbit and goat anti-mouse antibodies were purchased from
Calbiochem. The chemiluminescence SuperSignal kit was purchased
from Pierce and wortmannin from Sigma. A PKC-selective peptide
(Ac-FKKSFKL-NH2) [27] was synthesized in the laboratory of E.
Komives at the University of California at San Diego. PKC βII was puri-
fied from the baculovirus expression system, as previously described
[28]. Baculovirally expressed PKC α was partially purified by Q
Sepharose chromatography. PKC was stored at –20°C in 10 mM Tris
buffer pH 7.5 (4°C), 0.5 mM EDTA, 0.5 mM EGTA, 0.5 mM DTT,
150 mM KCl and 50% glycerol. The high-speed supernatant following
homogenization of rat brain in buffer containing 1% Triton X-100,
20 mM Tris buffer pH 7.5 (4°C), 1 mM EDTA, 1 mM EGTA, 1 mM DTT
was stored in an equal volume of glycerol at –20°C. GST-tagged
PDK-1 and a catalytically-inactive mutant of PDK-1 (containing point
mutation K110N) were expressed in Escherichia coli, purified on glu-
tathione-conjugated agarose (Pharmacia), and stored at –20°C in
12 mM Tris buffer pH 7.5 (4°C), 6 mM glutathione and 40% glycerol
[19]. Histidine-tagged constructs of the catalytic domain of PKC βII
(residues 286–673; Histidine tag at the amino terminus) and the
T447A/T448A/T500A triple mutant (J. Johnson, unpublished data)
were expressed in E. coli and purified on Probond nickel resin (Invitro-
gen) and stored at –20°C in 50 mM Tris buffer pH 7.5, 1% Triton X-
100, 1 mM EDTA, 1 mM EGTA, and 150 mM imidizole. Polyclonal
antibodies against the carboxyl terminus of PKC βII were purchased
from Santa Cruz Biotechnology and Calbiochem. Monoclonal antibod-
ies against PKC α or Myc were obtained from Transduction Laborato-
ries or Boehringer, respectively. A polyclonal antibody (P500) directed
against the phosphorylated activation loop of PKC βII was generated
by immunizing rabbits with a phosphopeptide based on the sequence:
494DGVTTKpTFCGTPD506 (pT refers to phospho-Thr, corresponding
to Thr500). The specificity for the activation loop phosphate has been
previously described [19]: P500 specifically labels the phosphorylated
activation loop of conventional, novel, and atypical PKC isozymes but
not the unphosphorylated proteins (based on the detection limit of our
assay, there is a >100-fold increase in immunoreactivity for phospho-
rylated species compared with unphosphorylated species; this anti-
body does not label the carboxy-terminal sites nor additional in vitro
autophosphorylation sites [19]). An antibody directed against phos-
phorylated Thr634 (strong reactivity) and Thr641 (weak reactivity) [21]
was provided by David Sweatt (Baylor College of Medicine), and one
directed against phosphorylated Ser660 was provided by Michael
Comb (New England Biolabs). The cDNA for rat PKC βII [29] was a
gift from Daniel E. Koshland, Jr. (University of California, Berkeley). The
catalytic subunit of protein phosphatase 1 was a gift from Anna
DePaoli-Roach (Indiana University). 
PDK-1 phosphorylation of PKC
Full-length PKC βII or α (approximately 3 nM) was incubated with purified
PDK-1 or PDK-1inact (40 nM) in 10 mM HEPES pH 7.5, 500 µM ATP,
50 µM MgCl2 and 1 mM DTT at 30°C for 1 h, unless otherwise stated. In
some experiments, 200 µM CaCl2 and sonicated vesicles (100 µM total
lipid) composed of diacylglycerol : phosphatidylserine : phosphatidyl-
choline (5:40:55 mol fraction), PI(3,4,5)P3 : phosphatidylcholine (10:90
mol fraction), or diacylglycerol : PI(3,4,5)P3 : phosphatidylserine : phos-
phatidylcholine (5:10:40:45 mol fraction) were included in the phospho-
rylation mixture. Two kinase-domain constructs (30 nm), wild-type PKC
βII catalytic domain or T447A/T448A/T500A catalytic domain, were
incubated with purified PDK-1 or PDK-1inact (40 nM) in 10 mM HEPES
buffer pH 7.5, 500 µM ATP, 50 µM MgCl2 at 30°C for 1 h, unless other-
wise stated. Dephosphorylated PKC was obtained by incubating pure
PKC βII (6 nM) with the catalytic subunit of protein phosphatase 1
(15 nM) in the presence of 10 mM HEPES buffer pH 7.5, 200µM MnCl2,
1 mM DTT, 200 µM CaCl2, and multilammellar suspensions of 140µM
phosphatidylserine, 4 µM diacylglycerol at 22°C for 30 min, as described
[12]. The dephosphorylation reaction was stopped by the addition of
1 µM microcystin. The dephosphorylated protein was then incubated, in
the same reaction mixture, with PDK-1 or PDK-1inact (30 nM) in the pres-
ence of 500 µM ATP and 50 µM MgCl2, as described above, for 1 h at
30°C. Reactions were quenched by the addition of 1/5 volume of
SDS–PAGE sample buffer [28]. Proteins were separated by
SDS–PAGE (7% polyacrylamide) and electrophoretically transferred to
PVDF membranes. Western blots were performed by probing PVDF
membranes with the indicated primary antibodies, incubating with peroxi-
dase-conjugated secondary antibodies, and detecting labeling with
chemiluminescence. In some cases, western blots were analyzed using a
BioRad Molecular Imager System in order to quantify antibody labeling.
Determination of catalytic domain stoichiometry
Purified PKC βII catalytic domain (15 nM) was incubated with PDK-1
or PDK-1inact (80 nM) at 30°C in the presence of 10 mM HEPES
buffer pH 7.5, 500 µM [γ-32P]ATP, 50 µM MgCl2 for 1–60 min. At
60 min, an additional 70 nM PDK-1 or PDK-1inact was added and the
reaction was allowed to continue for an additional 30 min. Phosphory-
lation reactions were quenched by the addition of 1/5 volume
SDS–PAGE sample buffer; proteins were separated by SDS–PAGE
and stained with Coomassie blue. Bands containing the catalytic
domain were excised from the gel and 32P incorporation was deter-
mined by liquid scintillation counting in 5 ml scintillation fluid (Biosafe
II, Research International Corp.).
PKC activity after phosphorylation by PDK-1 
PKC α, βII, or rat brain Triton X-100 soluble supernatant (all containing
approximately 0.3 nmol PKC) were incubated with PDK-1 or PDK-1inact
(20 nM) in 10 mM HEPES, 1 mM DTT and 100 µM [γ-32P]ATP for
30 min at 30°C. PKC activity was measured by adding 150 nM selec-
tive peptide in the presence or absence of lipid (140 µM phos-
phatidylserine and 4 µM diacylglycerol) and 125 µM CaCl2 in a final
volume of 80 µl for 5–7 min at 30°C. Reactions were quenched by the
addition of 25 µl of a solution containing 0.1 M ATP and 0.1 M EDTA
(pH 8–9). Aliquots (85 µl) were spotted onto P81 ion-exchange chro-
matography paper and washed four times with 0.4% (v/v) phosphoric
acid and once with 95% ethanol; 32P incorporation was then detected
by liquid scintillation counting in 5 ml scintillation fluid.
Co-expression of PKC and PDK-1 in COS-7 cells
COS-7 cells were transfected with 0.5 µg vector DNA (pcDNA3),
0.5 µg PKC βII or PKC α DNA (in pcDNA3), or 0.5 µg PKC βII or
PKC α DNA (in pcDNA3) and 2 µg Myc-tagged PDK-1 or PDK-1inact
DNA [19] using the Superfect transfection method (Qiagen). DNA was
added to 150 µl serum-free DMEM and 15 µl Superfect reagent and
incubated at 22°C for 5 min. The DNA-containing mixture was added to
cells plated at 70% confluency on 6-well tissue culture dishes. Cells
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were incubated overnight at 37°C, and then washed with DMEM con-
taining 10% FBS. Cells were harvested 48 h after transfection in
250 µl lysis buffer containing 20 mM HEPES buffer pH 7.5, 1% Triton
X-100, 1 mM DTT, 300 µM PMSF, 200 µM benzamidine, 40 µg ml–1
leupeptin and 100 nM microcystin. Proteins in cell lysates were sepa-
rated by SDS–PAGE (7% polyacrylamide) and electrophoretically
transferred to PVDF membranes. PKC was detected by western blot
analysis, as described above. The PKC activity in 5 µl COS-7 cell
lysate was obtained by measuring the Ca2+–lipid-dependent phospho-
rylation of a PKC-selective peptide, as described [22].
Immunoprecipitation
293 cells were transfected with Myc-tagged PDK-1 cDNA (0.4 µg)
alone or with PKC βII cDNA (0.6 µg) using the Lipofectamine (Life
Technologies) procedure, incubated for 12 h in DMEM plus 10% heat-
inactivated FBS, and then serum-starved by incubation in DMEM (no
serum) for 24 h, as described [19]. Cells were then treated with DMEM
containing 10% FBS for 20 min and then subjected to lysis as
described [19]. In some cases, cells were treated with 100 nM wort-
mannin for 20 min prior to incubation with FBS. PDK-1 was immuno-
precipitated with the anti-Myc monoclonal antibody 9E10 (Boehringer
Mannheim), samples analyzed on 7.5% polyacrylamide gels, and blots
probed with antibodies to PKC βII (Santa Cruz). PDK-1 and PKC βII
expression was confirmed by western blot analysis of whole cell lysates
using antibodies to the Myc tag or PKC βII, respectively.
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